Story

Procter & Gamble to Acquire Supplement Maker Thorne for $3.8 Billion

ENTHMSVIIDZHZH-TWJAKOHI
Aug 4, 20261 min read
Procter & Gamble to Acquire Supplement Maker Thorne for $3.8 Billion
Text size
Background

Procter & Gamble (NYSE: PG) has reached an agreement to acquire supplement manufacturer Thorne for $3.8 billion, a move confirmed by P&G CEO Shailesh Jejurikar. The deal, disclosed during a Tuesday appearance on CNBC, marks a significant expansion of the consumer goods giant's presence in the health and wellness market.

Strategic Expansion

The acquisition aligns with P&G's stated goal of growing its beauty and wellness business through strategic purchases. Jejurikar told CNBC that the company has been actively seeking opportunities to bolster this segment of its portfolio.

Thorne, which was founded in 1984, produces a wide range of nutritional supplements, from creatine to prenatal vitamins. According to CNBC, the company was projected to achieve total sales of $650 million in 2026.

Sample IUX Markets – In-articleAd

Market Context

Thorne has been the subject of acquisition rumors for several months. According to the Financial Times, UK-based consumer health companies Haleon Plc and Unilever Plc were also reported as potential bidders, highlighting the competitive interest in the supplement brand.

This transaction represents a substantial increase in valuation for Thorne. The company was taken private in 2023 by L Catterton, a private equity firm backed by LVMH, for $680 million. The $3.8 billion price tag from P&G underscores the rapid growth and perceived value in the wellness and supplement industry.

Read next

More on Stocks
Back to latest news

LATEST